Table Of Contents

1. Introduction 15
1.1. Objectives Of The Study 15
1.2. Market Definition 15
1.3. Overview Of North America Skin Graft Market 15
1.4. Currency And Pricing 16
1.5. Limitation 16
1.6. Markets Covered 17
2. Market Segmentation 19
2.1. Markets Covered 19
2.2. Geographic Scope 20
2.3. Years Considered For The Study 21
2.4. Currency And Pricing 21
2.5. Research Methodology 22
2.6. Primary Interviews With Key Opinion Leaders 25
2.7. Secondary Sources 26
2.8. Assumptions 26
3. Market Overview 27
3.1. Drivers 29
3.1.1. Increasing Number Of Burns Injuries, Pressure Ulcers And Skin Infections 29
3.1.2. Technological Advancements And Developments In Skin Grafting Techniques 30
3.1.3. Favorable Reimbursement Policies For Skin Grafting Procedure 31
3.2. Restraints 32
3.2.1. Side Effects Related To The Skin Graft Procedure 32
3.3. Opportunities 33
3.3.1. Increasing Medical Tourisms 33
3.4. Challenges 34
3.4.1. Competition Among Major Players 34
4. Executive Summary 35
5. Premium Insights 37
6. North America Skin Graft Market, By Type 40
6.1. Overview 41
6.2. Autologous 43
6.3. Isogeneic 44
6.4. Allogeneic 45
6.5. Xenogeneic 46
6.6. Prosthetic 47
7. North America Skin Graft Market, By Graft Thickness 48
7.1. Overview 49
7.2. Split-Thickness 51
7.3. Full-Thickness 52
7.4. Composite Graft 53
8. North America Skin Graft Market, By Application 54
8.1. Overview 55
8.2. Burns 57
8.3. Extensive Wound 58
8.4. Extensive Skin Loss Due To Infection 59
8.5. Skin Cancer 60
9. North America Skin Graft Market, By Equipment Type 61
9.1. Overview 62
9.2. Dermatome 64
9.2.1. Knife Dermatomes 66
9.2.1.1. Blair/Brown Knife 67
9.2.1.2. Watson Knife 67
9.2.1.3. Cobbett Knife 67
9.2.2. Drum Dermatomes 68
9.2.2.1. Padgett Dermatomes 68
9.2.2.2. Reese Dermatomes 69
9.2.3. Electrical Dermatomes 69
9.2.4. Air-Powdered Dermatomes 70
9.3. General Surgical Instruments 71
9.4. Consumables 72
9.5. Others 73
10. North America Skin Graft Market, By End User 74
10.1. Overview 75
10.2. Hospitals 77
10.3. Dermatology Clinics 78
10.4. Ambulatory Surgical Centers 79
11. North America Skin Graft Market, By Geography 80
11.1. North America 80
11.1.1. U.S. 91
11.1.2. Canada 95
11.1.3. Mexico 99
12. North America Skin Graft Market, Company Landscape 104
12.1. Company Share Analysis; North America 104
13. Company Profiles 105
13.1. Integra Lifesciences Corporation 105
13.1.1. Company Overview 105
13.1.2. Integra Lifesciences Corporation; Revenue Analysis 106
13.1.3. Product Portfolio 107
13.1.4. Recent Developments 108
13.2. Organogenesis Inc. 109
13.2.1. Company Overview 109
13.2.2. Organogenesis Inc.; Company Snapshot 109
13.2.3. Product Portfolio 110
13.2.4. Recent Developments 110
13.3. Zimmer Biomet 111
13.3.1. Company Overview 111
13.3.2. Zimmer Biomet; Revenue Analysis 111
13.3.3. Product Portfolio 112
13.3.4. Recent Developments 113
13.4. B. Braun Melsungen Ag 114
13.4.1. Company Overview 114
13.4.2. B. Braun Melsungen Ag; Revenue Analysis 114
13.4.3. Product Portfolio 115
13.4.4. Recent Developments 115
13.5. Avita Medical 116
13.5.1. Company Overview 116
13.5.2. Avita Medical; Revenue Analysis 116
13.5.3. Product Portfolio 117
13.5.4. Recent Developments 117
13.6. De Soutter Medical 118
13.6.1. Company Overview 118
13.6.2. De Soutter Medical; Company Snapshot 118
13.6.3. Product Portfolio 118
13.6.4. Recent Developments 118
13.7. Exsurco Medical, Inc. 119
13.7.1. Company Overview 119
13.7.2. Exsurco Medical, Inc.;Company Snapshot 119
13.7.3. Product Portfolio 120
13.7.4. Recent Developments 120
13.8. Mallinckrodt 121
13.8.1. Company Overview 121
13.8.2. Mallinckrodt; Revenue Analysis 121
13.8.3. Product Pipeline 122
13.8.4. Recent Developments 122
13.9. Nouvag 123
13.9.1. Company Overview 123
13.9.2. Nouvag; Company Snapshot 123
13.9.3. Product Portfolio 123
13.9.4. Recent Developments 123
13.10. Surtex Instruments Limited 124
13.10.1. Company Overview 124
13.10.2. Surtex Instruments Limited; Company Snapshot 124
13.10.3. Product Portfolio 125
13.10.4. Recent Developments 125
13.11. Tissue Regenix 126
13.11.1. Company Overview 126
13.11.2. Tissue Regenix; Revenue Analysis 126
13.11.3. Product Portfolio 127
13.11.4. Recent Developments 127
14. Related Reports 128